Estados Unidos - inglés - NLM (National Library of Medicine)

pfizer laboratories div pfizer inc - misoprostol (unii: 0e43v0bb57) (misoprostol - unii:0e43v0bb57) - misoprostol 100 ug - cytotec (misoprostol) is indicated for reducing the risk of nsaid (nonsteroidal anti-inflammatory drugs, including aspirin)–induced gastric ulcers in patients at high risk of complications from gastric ulcer, e.g., the elderly and patients with concomitant debilitating disease, as well as patients at high risk of developing gastric ulceration, such as patients with a history of ulcer. cytotec has not been shown to reduce the risk of duodenal ulcers in patients taking nsaids. cytotec should be taken for the duration of nsaid therapy. cytotec has been shown to reduce the risk of gastric ulcers in controlled studies of 3 months' duration. it had no effect, compared to placebo, on gastrointestinal pain or discomfort associated with nsaid use. see boxed warnings. cytotec should not be taken by pregnant women to reduce the risk of ulcers induced by nonsteroidal anti-inflammatory drugs (nsaids). cytotec should not be taken by anyone with a history of allergy to prostaglandins.

Estados Unidos - inglés - NLM (National Library of Medicine)

pd-rx pharmaceuticals, inc. - misoprostol (unii: 0e43v0bb57) (misoprostol - unii:0e43v0bb57) - misoprostol 100 ug - cytotec (misoprostol) is indicated for reducing the risk of nsaid (nonsteroidal anti-inflammatory drugs, including aspirin)–induced gastric ulcers in patients at high risk of complications from gastric ulcer, e.g., the elderly and patients with concomitant debilitating disease, as well as patients at high risk of developing gastric ulceration, such as patients with a history of ulcer. cytotec has not been shown to reduce the risk of duodenal ulcers in patients taking nsaids. cytotec should be taken for the duration of nsaid therapy. cytotec has been shown to reduce the risk of gastric ulcers in controlled studies of 3 months' duration. it had no effect, compared to placebo, on gastrointestinal pain or discomfort associated with nsaid use. see boxed warnings. cytotec should not be taken by pregnant women to reduce the risk of ulcers induced by nonsteroidal anti-inflammatory drugs (nsaids). cytotec should not be taken by anyone with a history of allergy to prostaglandins.

Canadá - inglés - Health Canada

genmed a division of pfizer canada ulc - diclofenac sodium; misoprostol - tablet (delayed-release) - 50mg; 200mcg - diclofenac sodium 50mg; misoprostol 200mcg - other nonsteroidal antiimflammatory agents

Canadá - inglés - Health Canada

genmed a division of pfizer canada ulc - diclofenac sodium; misoprostol - tablet (delayed-release) - 75mg; 200mcg - diclofenac sodium 75mg; misoprostol 200mcg - other nonsteroidal antiimflammatory agents

Canadá - inglés - Health Canada

pharmascience inc - diclofenac sodium; misoprostol - tablet (delayed-release) - 50mg; 200mcg - diclofenac sodium 50mg; misoprostol 200mcg - other nonsteroidal antiimflammatory agents

Canadá - inglés - Health Canada

pharmascience inc - diclofenac sodium; misoprostol - tablet (delayed-release) - 75mg; 200mcg - diclofenac sodium 75mg; misoprostol 200mcg - other nonsteroidal antiimflammatory agents

Canadá - inglés - Health Canada

aa pharma inc - misoprostol - tablet - 100mcg - misoprostol 100mcg - prostaglandins

Canadá - inglés - Health Canada

aa pharma inc - misoprostol - tablet - 200mcg - misoprostol 200mcg - prostaglandins

Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - misoprostol 200ug (misoprostol:hpmc dispersion 1:100 = 20.2mg/tablet) - tablet - 200 mcg - active: misoprostol 200ug (misoprostol:hpmc dispersion 1:100 = 20.2mg/tablet) excipient: hydrogenated castor oil microcrystalline cellulose sodium starch glycolate - cytotec is indicated for coadministration with non-steroidal anti-inflammatory drugs (nsaids) for the prevention of ulcers and erosions induced by nsaids in adults. cytotec is indicated for the treatment of duodenal and gastric ulcers in adults. cytotec is also effective in healing a significant number of duodenal ulcers refractory to h2-blocker therapy. cytotec is indicated for the treatment of erosive gastroduodenitis associated with peptic ulcer disease in adults. cytotec is indicated in prevention of stress-induced upper gi mucosal bleeding and lesions in post-surgical adult icu patients.

Estados Unidos - inglés - NLM (National Library of Medicine)

proficient rx lp - misoprostol (unii: 0e43v0bb57) (misoprostol - unii:0e43v0bb57) - misoprostol is indicated for reducing the risk of nsaid (nonsteroidal anti-inflammatory drugs, including aspirin)–induced gastric ulcers in patients at high risk of complications from gastric ulcer, e.g., the elderly and patients with concomitant debilitating disease, as well as patients at high risk of developing gastric ulceration, such as patients with a history of ulcer. misoprostol has not been shown to reduce the risk of duodenal ulcers in patients taking nsaids. misoprostol should be taken for the duration of nsaid therapy. misoprostol has been shown to reduce the risk of gastric ulcers in controlled studies of 3 months' duration. it had no effect, compared to placebo, on gastrointestinal pain or discomfort associated with nsaid use. see boxed warnings. misoprostol should not be taken by pregnant women to reduce the risk of ulcers induced by nonsteroidal anti-inflammatory drugs (nsaids). misoprostol should not be taken by anyone with a history of allergy to prostaglandins.